Cargando…

Antidepressant effect r TMS during pregnancy in a case of Major Depression Resistant to Pharmacological Treatment

Major depressive disorder (MDD) is a common complication of pregnancy and the postpartum period. Approximately 5% of women who have MDD during pregnancy or the postpartum period meet criteria for resistant depression, associated with increased morbidity in both the newborn and the pregnant woman. Cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isabel, Martínez-Gras, Rosa, Jurado-Barba, Luis, Sánchez-Pastor, Gabriel, Rubio, Julio, Prieto-Montalvo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Actas Espanolas Psiquiatria 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335080/ https://www.ncbi.nlm.nih.gov/pubmed/34734643

Ejemplares similares

Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?
por: Jurado-Barba, Rosa, et al.
Publicado: (2020)

Mapping Inter-individual Functional Connectivity Variability in TMS Targets for Major Depressive Disorder
por: Harita, Shreyas, et al.
Publicado: (2022)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care
por: Salazar-Fraile, José, et al.
Publicado: (2018)

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
por: Xin, Juncai, et al.
Publicado: (2020)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
por: Wang, Qiang, et al.
Publicado: (2022)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
por: Safer, Daniel J., et al.
Publicado: (2019)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
por: Zhao, Lei, et al.
Publicado: (2022)

Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study
por: Chou, Po-Han, et al.
Publicado: (2023)

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
por: Lin, Eugene, et al.
Publicado: (2018)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

rTMS Therapy Reduces Hypofrontality in Patients With Depression as Measured by fNIRS
por: Kawabata, Yasuo, et al.
Publicado: (2022)

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Kennedy, Kevin P.
Publicado: (2022)

Is There a Role of Autophagy in Depression and Antidepressant Action?
por: Gassen, Nils C., et al.
Publicado: (2019)

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Henssler, Jonathan, et al.
Publicado: (2023)

Neurophysiological Biomarkers in Schizophrenia—P50, Mismatch Negativity, and TMS-EMG and TMS-EEG
por: Kim, Helena K., et al.
Publicado: (2020)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness
por: Roughan, William H., et al.
Publicado: (2021)

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study
por: Agorastos, Agorastos, et al.
Publicado: (2020)

Prescribing behavior of antidepressants for depressive disorders: A systematic review
por: Lam, Mary K., et al.
Publicado: (2022)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
por: Luo, Yan, et al.
Publicado: (2020)

Early Improvement Predicts Clinical Outcomes Similarly in 10 Hz rTMS and iTBS Therapy for Depression
por: Spitz, Nathen A., et al.
Publicado: (2022)

Moderators of the response to deep TMS for smoking addiction
por: Gersner, Roman, et al.
Publicado: (2023)

Corrigendum: National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
por: Luo, Yan, et al.
Publicado: (2020)

Deficits in specific executive functions manifest by severity in major depressive disorder: a comparison of antidepressant naïve inpatient, outpatient, subclinical, and healthy control groups
por: Malekizadeh, Hossein, et al.
Publicado: (2023)

Trends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
por: Yu, Zhenwei, et al.
Publicado: (2020)

Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression
por: Harika-Germaneau, Ghina, et al.
Publicado: (2022)

Depression and/or PTSD Comorbidity Affects Response to Antidepressants in Those With Alcohol Use Disorder
por: Na, Peter J., et al.
Publicado: (2022)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Evaluation of Antidepressant Effect of Minocycline in Alcohol Abstinence-Induced Depression Model in Mice
por: Gajbhiye, Snehalata, et al.
Publicado: (2022)

Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients
por: Losenkov, Innokentiy S., et al.
Publicado: (2020)

How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery Project
por: Rubio, Gabriel, et al.
Publicado: (2023)

Chronic caffeine consumption curbs rTMS-induced plasticity
por: Vigne, Megan, et al.
Publicado: (2023)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

Cerebellar Contributions to Major Depression
por: Depping, Malte S., et al.
Publicado: (2018)

Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression
por: Chen, Shaw-Ji, et al.
Publicado: (2013)

Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot Study
por: Bhattacharyya, Pallab, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s5p8d6fd69md0egiav1i797n0v